BTI
CELL

Blue Trust Inc’s PhenomeX Inc. Common Stock CELL Stock Holding History

Blue Trust Inc’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-470
Closed -$2K – 2648
2023
Q1 		$2K Buy
+470
New +$859 ﹤0.01% 2076

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blue Trust Inc's CELL Position: Q2 2023 in Review

Blue Trust Inc sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 470 shares — an estimated $2K sold.

Blue Trust Inc first reported a position in CELL in Q1 2023 and held it in 1 quarter. The position peaked at $2K in Q1 2023. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Blue Trust Inc reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Blue Trust Inc sold 470 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $2K.
  • Blue Trust Inc first reported a position in PhenomeX Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Blue Trust Inc's PhenomeX Inc. Common Stock position peaked at $2K in Q1 2023.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Blue Trust Inc's 13F filing for Q2 2023, filed 14 Jul 2023.